Abbott Seeks Declaratory Judgment Against J&J
Less than a week after launching a new line of drug-eluting coronary stents in Europe, Abbott Laboratories has sought declaratory judgment, trying to quell the threat of a patent infringement suit...To view the full article, register now.
Already a subscriber? Click here to view full article